ASHG 2026 · Tools, software & services

EpiSign at ASHG 2026

London, Canada

EpiSign at ASHG 2026 in Montréal: Booth 1303.

1303
exhibit booth

Explore everyone at ASHG 2026 →

OrganizationASHG 2026 Attendance
EpiSign
London, Canada
EpiSign sells DNA-methylation diagnostic assays and cloud software for clinical and research laboratories investigating rare genetic disorders.
Integrated its episignature tests into DECIPHER, a widely used genomic-data interpretation database, increasing visibility to clinical geneticists.
Integrated its episignature tests into DECIPHER, a widely used genomic-data interpretation database, increasing visibility to clinical geneticists.
2026-07 · source
Launched EpiSign v6, expanding coverage to over 310 episignature conditions, a significant expansion of its rare-disease diagnostic menu.
2026-06 · source
Joined a funded Ontario Genomics initiative building a secure cloud framework for rare-disease diagnostics, adding a government-backed collaboration.
2026-03 · source
Source: company newsroom
Booth
Exhibiting at Booth 1303
Wed, Oct 219:45am–4:30pmThu, Oct 229:45am–1:30pmFri, Oct 239:45am–4:30pm

Explore the full ASHG 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Montréal. Leave your work email and we’ll be in touch.

Privacy

Meeting EpiSign in Montréal?

Get in-depth attendee and institution profiles and research, to plan your meetings in Montréal. Leave your work email and we’ll be in touch.

Privacy

Not affiliated with or endorsed by the American Society of Human Genetics. Submit a correction